- Home
- LSTA vs SCNX Comparison
LSTA vs SCNX Comparison
Compare LSTA & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- SCNX
- Stock Information
- Founded
- LSTA 1980
- SCNX 2010
- Country
- LSTA United States
- SCNX United States
- Employees
- LSTA N/A
- SCNX N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- SCNX Other Pharmaceuticals
- Sector
- LSTA Health Care
- SCNX Health Care
- Exchange
- LSTA Nasdaq
- SCNX Nasdaq
- Market Cap
- LSTA 20.9M
- SCNX 14.4M
- IPO Year
- LSTA N/A
- SCNX 2020
- Fundamental
- Price
- LSTA $2.80
- SCNX $0.98
- Analyst Decision
- LSTA Strong Buy
- SCNX
- Analyst Count
- LSTA 1
- SCNX 0
- Target Price
- LSTA $15.00
- SCNX N/A
- AVG Volume (30 Days)
- LSTA 14.5K
- SCNX 129.8K
- Earning Date
- LSTA 08-11-2025
- SCNX 08-10-2025
- Dividend Yield
- LSTA N/A
- SCNX N/A
- EPS Growth
- LSTA N/A
- SCNX N/A
- EPS
- LSTA N/A
- SCNX N/A
- Revenue
- LSTA $1,000,000.00
- SCNX $146,901.00
- Revenue This Year
- LSTA N/A
- SCNX N/A
- Revenue Next Year
- LSTA N/A
- SCNX N/A
- P/E Ratio
- LSTA N/A
- SCNX N/A
- Revenue Growth
- LSTA N/A
- SCNX N/A
- 52 Week Low
- LSTA $1.87
- SCNX $0.69
- 52 Week High
- LSTA $4.20
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- LSTA 59.64
- SCNX N/A
- Support Level
- LSTA $2.36
- SCNX N/A
- Resistance Level
- LSTA $2.69
- SCNX N/A
- Average True Range (ATR)
- LSTA 0.22
- SCNX 0.00
- MACD
- LSTA 0.02
- SCNX 0.00
- Stochastic Oscillator
- LSTA 62.50
- SCNX 0.00
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.